Skip to main content
SpringerLink
Log in

Neuro-oncological Disorders in Women

  • Chapter
  • First Online:
Neurology and Psychiatry of Women

  • 771 Accesses

Abstract

Neuro-Oncology of Women (N.O.W.) is aimed to bring awareness to and increase research around pertinent neuro-oncology issues over the changing microenvironmental states over the female lifespan. Few neuro-oncologic diseases have validated clinical guidelines pertaining to pubescent, reproductive-aged, or peri/post-menopausal females. While some of the most common intracranial tumors predominantly affect women, guiding research on the use of hormone therapies, fertility, pregnancy, and tumor monitoring during pregnancy or perimenopausal stages are lacking. Questions about specialized tumor surveillance, pregnancy prevention/promotion, and fertility/pregnancy risks for tumor treating devices and immunotherapies are not confidently answered. As cancer therapies extend patient overall-survival, clinicians must be increasingly prepared to address brain tumors in women at various life-stages. Finally, the psycho-social impact on women and their families is discussed. Here, we feature neuro-oncology conditions in women and emphasize the common patient and clinician concerns.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 79.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Change history

  • 10 May 2019

    This book was inadvertently published with the below errors:

References

  1. Murrell DH, Foster PJ. Brain metastasis: basic biology, clinical management, and insight from experimental model systems. In: Introduction to cancer metastasis. Aamir Ahmad. Elsevier UK. 2017. p. 317–333.

    Google Scholar 

  2. Braganza MZ, Kitahara CM, Berrington de Gonzalez A, Inskip PD, Johnson KJ, Rajaraman P. Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro-Oncology. 2012;14(11):1316–24.

    Article  Google Scholar 

  3. Turner MC. Epidemiology: allergy history, IgE, and cancer. Cancer Immunol Immunother. 2012;61:1493–510.

    Article  CAS  Google Scholar 

  4. Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united states in 2009–2013. Neuro-Oncology. 2016;18(5):1–75.

    Article  Google Scholar 

  5. Schlehofer B, Blettner M, Wahrendorf J. Association between brain tumors and menopausal status. J Natl Cancer Inst. 1992;84(17):1346–9.

    Article  CAS  Google Scholar 

  6. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7(4):279–87.

    PubMed  Google Scholar 

  7. Simon RH. Brain tumors in pregnancy. Semin Neurol. 1988;8(3):214–21.

    Article  CAS  Google Scholar 

  8. Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016;316(9):952–61.

    Article  Google Scholar 

  9. Markwalder TM, Zara DT, Goldhirsch A, Markwalder RV. Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features. Surg Neurol. 1983;20:42–7.

    Article  CAS  Google Scholar 

  10. Black PM. Meningiomas. Neurosurgery. 1993;32:643–57.

    Article  CAS  Google Scholar 

  11. Chamberlain MC, Barnholtz JS. Medical treatment of recurrent meningiomas. Exp Rev Neurothera. 2014;11(10):1425–32.

    Article  Google Scholar 

  12. Carroll RS, Zhang J, Dashner K, Sar M, Wilson EM, Black PM. Androgen receptor expression in meningiomas. J Neurosurg. 1995;82:453–60.

    Article  CAS  Google Scholar 

  13. Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, Schildkraut JM. Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg. 2013;118(3):649–56.

    Google Scholar 

  14. Blitshteyn S, Cook JE, Jaeckle KA. Is there an association between meningioma and hormone replacement therapy? J Clin Oncol. 2008;26(2):279–82.

    Article  CAS  Google Scholar 

  15. Qi Z, Shao C, Huang Y, Huo G, Zhou Y, Wang Z. Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis. PLoS One. 2013;8(12):e83261.

    Article  Google Scholar 

  16. Ji Y, Rankin C, Grunberg S, Sherrod AE, Ahmadi J, Townsend JJ, et al. Double-blind phase III randomized trial of the antiprogestin agent mifepristone in the treatment of unresectable meningioma: SWOG S9005. J Clin Oncol. 2015;33(34):4093–8.

    Article  CAS  Google Scholar 

  17. Rubinstein AB, Loren D, Geier A, Reichenthal E, Gadoth N. Hormone receptors in initially excised versus recurrent intracranial meningiomas. J Neurosurg. 1994;81:184–7.

    Article  CAS  Google Scholar 

  18. Yust-Katz S, de Groot JF, Liu D, Wu J, Yuan Y, Anderson MD, et al. Pregnancy and glial brain tumors. Neuro-Oncology. 2014;16(9):1289–94.

    Article  Google Scholar 

  19. Thapar K, Laws ER. Pituitary tumors. In: Kaye AH, Laws ER, editors. Brain tumors. New York: Churchill Livingstone; 1995. p. 759–76.

    Google Scholar 

  20. Randall RV, Laws ER, Abboud CF, Ebersold MJ, Kao PC, Scheithauer BW. Transphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients. Mayo Clin Proc. 1983;58:108–21.

    CAS  PubMed  Google Scholar 

  21. Swain SM. Triple-negative breast cancer: metastatic risk and role of platinum agents. Paper presented at: 44th Annual Meeting of the American Society of Clinical Oncology; May 30–June 3, 2008; Chicago.

    Google Scholar 

  22. Glick RP, Penny D, Hart A. The pre-operative and post-operative management of the brain tumor patient. In: Morantz RA, Walsh JW, editors. Brain tumors. New York: Marcel Dekker; 1994. p. 345–66.

    Google Scholar 

  23. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst. 2011;103(6):470.

    Article  Google Scholar 

  24. Forsyth PJ, Cascino TL. Neurological complications of chemotherapy. In: Wiley RG, editor. Neurological complications of cancer. New York: Marcel Dekker; 1995. p. 241–66.

    Google Scholar 

  25. Posner JB. Neurologic complications of cancer. Philadelphia: F. A. Davis Company; 1995.

    Google Scholar 

  26. Graus F, Vega F, Delattre JY, Bonaventura I, Rene R, Arbaiza D, et al. Plasmapharesis and antineoplastic treatment in central nervous system paraneoplastic syndromes with antineuronal autoantibodies. Neurology. 1992;42:536–40.

    Article  CAS  Google Scholar 

  27. OncLink. Men’s guide to sexuality during & after cancer treatment [Internet]. Philadelphia: The Abramson Cancer Center of the University of Pennsylvania. [updated 2017 June 20]. Available from: https://www.oncolink.org/support/sexuality-fertility/sexuality/men-s-guide-to-sexuality-during-after-cancer-treatment

  28. Müller C, Holtschmidt J, Auer M, Heitzer E, Lamszus K, Schulte A, et al. Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med. 2014;6(247):247.

    Article  Google Scholar 

  29. Gao F, Cui Y, Jiang H, Dali S, Wang Y, Jiang Z, et al. Circulating tumor cell is a common property of brain glioma and promotes the monitoring system. Oncotarget. 2016;7(44):71330–40.

    PubMed  PubMed Central  Google Scholar 

  30. Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA. 2004;292(1):75–80.

    Article  CAS  Google Scholar 

  31. Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, et al. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;314(23):2535–43.

    Article  CAS  Google Scholar 

  32. Chan WN, Gurnot C, Montine TJ, Sonnen JA, Guthrie KA, Nelson JL. Male microchimerism in the human female brain. PLoS One. 2012;7(9):e45592.

    Article  CAS  Google Scholar 

  33. Carlson RH. Study: women with brain tumors have 10 times rate of divorce as men with brain tumors. Oncol Times. 2001;23(8):63.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Geisinger Neuroscience Institute, Danville, PA, USA

    Na Tosha N. Gatson & Erika N. Leese

  2. Geisinger Cancer Institute, Danville, PA, USA

    Na Tosha N. Gatson

Authors
  1. Na Tosha N. Gatson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erika N. Leese
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Na Tosha N. Gatson .

Editor information

Editors and Affiliations

  1. Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA

    Mary Angela O’Neal

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gatson, N.T.N., Leese, E.N. (2019). Neuro-oncological Disorders in Women. In: O’Neal, M. (eds) Neurology and Psychiatry of Women. Springer, Cham. https://doi.org/10.1007/978-3-030-04245-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-04245-5_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-04244-8

  • Online ISBN: 978-3-030-04245-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation